secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001213900-24-056224
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive Therapeutics doubles authorized common stock to 400M shares
---------------------------------------------------------------------

- Stockholders approved increase from 200M to 400M shares on June 20, 2024.
- Certificate of Amendment filed with Delaware on June 21, 2024, effective immediately.
- No specific use of the additional shares or dilution impact disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024056224/0001213900-24-056224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024056224/ea0208510-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-056224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer